CVE:NXG NexgenRx (NXG) Stock Price, News & Analysis C$0.63 +0.01 (+1.61%) As of 11:20 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About NexgenRx Stock (CVE:NXG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NexgenRx alerts:Sign Up Key Stats Today's RangeC$0.63▼C$0.6350-Day RangeC$0.45▼C$0.7052-Week RangeC$0.29▼C$0.75Volume541 shsAverage Volume55,373 shsMarket CapitalizationC$44.80 millionP/E Ratio20.32Dividend Yield2.38%Price TargetN/AConsensus RatingN/A Company Overview NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada. Read More Receive NXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NXG Stock News HeadlinesMicro cap, big flex: NexgenRx delivers a breakout quarterAugust 21, 2026 | msn.comNexgenRx Announces Second Quarter Results (With Substantial Increases in Revenue, EBITDA and Financial Position) and Declaration of DividendAugust 20, 2026 | theglobeandmail.comThe ultimate IPO unicorn before Labor DayAnthropic is now valued at over $1 trillion, more than every U.S. airline combined and larger than the U.S. defense budget. Its annualized revenue grew 80x in the first quarter, and an IPO could arrive as early as October. For a limited time, investors can access a report detailing how to explore a pre-IPO stake in Anthropic for $29, a 94% discount off the retail price. The package includes a year of Disruptors and Dominators, monthly stock ideas, and four special reports.September 4 at 1:00 AM | Weiss Ratings (Ad)NexgenRx Inc.: NexgenRx Announces Second Quarter Results and Declaration of DividendAugust 20, 2026 | finanznachrichten.deNexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA GrowthMay 22, 2026 | theglobeandmail.comHere's Why We Think NexgenRx (CVE:NXG) Might Deserve Your Attention TodayApril 28, 2026 | finance.yahoo.comNexgenRx Announces Declaration of DivdendsDecember 10, 2025 | finance.yahoo.comNexgenRx Reports Strong Q3 2025 Financial GrowthNovember 21, 2025 | msn.comSee More Headlines NXG Stock Analysis - Frequently Asked Questions How have NXG shares performed this year? NexgenRx's stock was trading at C$0.40 at the beginning of the year. Since then, NXG shares have increased by 57.5% and is now trading at C$0.63. How do I buy shares of NexgenRx? Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of NexgenRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that NexgenRx investors own include Vision Marine Technologies (VMAR), Hydro One (H) and Carvana (CVNA). Industry, Sector and Symbol Stock ExchangeCVE SectorHealthcare Industry Healthcare Plans Sub-IndustryN/A Current SymbolCVE:NXG CIKN/A Webwww.nexgenrx.com Phone+1-416-6953393FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.03 Trailing P/E Ratio20.32 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.06 million Net Margins-0.17% Pretax MarginN/A Return on Equity-0.31% Return on Assets0.42% Debt Debt-to-Equity Ratio6.16 Current Ratio1.08 Quick Ratio0.12 Sales & Book Value Annual SalesC$19.34 million Price / Sales2.32 Cash FlowC$0.07 per share Price / Cash Flow9.64 Book ValueC$0.09 per share Price / Book7.00Miscellaneous Outstanding Shares71,117,000Free FloatN/AMarket CapC$44.80 million OptionableNot Optionable Beta0.50 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (CVE:NXG) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersTrump’s “new Petrodollar” exposedTrump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...Porter & Company | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredMan Who Called SpaceX Rise Says Elon’s NEW Project is Even BiggerJames Altucher called the rise of Nvidia, Apple, and SpaceX years before the crowd. Now he says he has uncover...Paradigm Press | SponsoredHalf the market is standing on a trapdoorNearly half the value of the US stock market now sits in AI stocks - the most concentrated the market has been...Behind the Markets | SponsoredWall Street pays $32K for this type of stock market data. (But see this Labor Day deal now!)The Bloomberg Terminal costs $32,000 a year and sits on the desks of more than 350,000 Wall Street traders. Mo...Weiss Ratings | SponsoredThis Overlooked Fund Turns AI Stocks Into Weekly IncomeA small fund pays investors weekly income from AI stocks that don't pay dividends on their own. Chief Incom...Investors Alley | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
